Monday February 17, 2020

HPRA to raise fees to drug companies by 8%

Susan Mitchell

Deputy Editor and Health Editor

6th January, 2019

The medicines regulator is proposing to increase its fees to veterinary and pharma companies by 8 per cent.

In submissions to the Health Products Regulatory Authority (HPRA), representative groups warned that their members already faced increased costs due to Brexit and the implementation of the Falsified Medicines Directive.

In a statement, the Irish Pharmaceutical Healthcare Association (IPHA) said: “We consider the fees increase part of the overall Brexit cost which is being passed on to the...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Medical product supply chain could face interruption if virus continues to spread

Aaron Rogan | 1 day ago

Chief executive Paul Reid believes private care should be separate

Daniel Murray | 1 week ago

If an artist in the US can create a credible facial image of a smoker from DNA left on a discarded cigarette butt, imagine the potential power of genomic medicine, the vast awards awaiting those who possess access to genomes, and the potential for misuse where regulation of genetic information is light

Killian Woods | 1 week ago